Somatic cell reprogramming control: signaling pathway modulation versus transcription factor activities - PubMed (original) (raw)
. 2009 Apr 15;8(8):1138-44.
doi: 10.4161/cc.8.8.8206. Epub 2009 Apr 16.
Affiliations
- PMID: 19305152
- DOI: 10.4161/cc.8.8.8206
Somatic cell reprogramming control: signaling pathway modulation versus transcription factor activities
Frederic Lluis et al. Cell Cycle. 2009.
Abstract
In all cells of the body, differentiation from zygotes has been considered a unidirectional route. Recently, however, it has become clear that the reverse path is indeed possible, in the reprogramming of somatic nuclei, i.e., the de-differentiation of somatic cells into pluripotent stem-like cells. Breakthrough discoveries have shown that overexpression of a combination of transcription factors can allow a somatic cell nucleus to be reprogrammed. Furthermore, very recently it has been shown that modulation of the Wnt/beta-catenin, MAPK/ERK and PI3K/Akt signaling pathways strikingly enhances reprogramming efficiency. Despite these important findings, the molecular mechanisms driving reprogramming are still largely unknown, and moreover, it is not clear if and how these different routes for the triggering of somatic cell reprogramming converge, i.e., the overexpression of transcription factors and the modulation of signaling pathways. Here, we consider these different reprogramming routes and discuss how they can cooperate in parallel to enhance somatic cell reprogramming.
Similar articles
- Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion.
Lluis F, Pedone E, Pepe S, Cosma MP. Lluis F, et al. Cell Stem Cell. 2008 Nov 6;3(5):493-507. doi: 10.1016/j.stem.2008.08.017. Cell Stem Cell. 2008. PMID: 18983965 - Reprogramming cell fate to pluripotency: the decision-making signalling pathways.
Sanges D, Cosma MP. Sanges D, et al. Int J Dev Biol. 2010;54(11-12):1575-87. doi: 10.1387/ijdb.103190ds. Int J Dev Biol. 2010. PMID: 21305473 Review. - Wnt signaling promotes reprogramming of somatic cells to pluripotency.
Marson A, Foreman R, Chevalier B, Bilodeau S, Kahn M, Young RA, Jaenisch R. Marson A, et al. Cell Stem Cell. 2008 Aug 7;3(2):132-5. doi: 10.1016/j.stem.2008.06.019. Cell Stem Cell. 2008. PMID: 18682236 Free PMC article. No abstract available. - Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.
Huang HP, Chen PH, Yu CY, Chuang CY, Stone L, Hsiao WC, Li CL, Tsai SC, Chen KY, Chen HF, Ho HN, Kuo HC. Huang HP, et al. J Biol Chem. 2011 Sep 23;286(38):33520-32. doi: 10.1074/jbc.M111.256164. Epub 2011 Jul 28. J Biol Chem. 2011. PMID: 21799003 Free PMC article. - Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.
Jaenisch R, Young R. Jaenisch R, et al. Cell. 2008 Feb 22;132(4):567-82. doi: 10.1016/j.cell.2008.01.015. Cell. 2008. PMID: 18295576 Free PMC article. Review.
Cited by
- Temporal perturbation of the Wnt signaling pathway in the control of cell reprogramming is modulated by TCF1.
Aulicino F, Theka I, Ombrato L, Lluis F, Cosma MP. Aulicino F, et al. Stem Cell Reports. 2014 May 8;2(5):707-20. doi: 10.1016/j.stemcr.2014.04.001. eCollection 2014 May 6. Stem Cell Reports. 2014. PMID: 24936456 Free PMC article. - Rapamycin induces pluripotent genes associated with avoidance of replicative senescence.
Pospelova TV, Bykova TV, Zubova SG, Katolikova NV, Yartzeva NM, Pospelov VA. Pospelova TV, et al. Cell Cycle. 2013 Dec 15;12(24):3841-51. doi: 10.4161/cc.27396. Epub 2013 Dec 2. Cell Cycle. 2013. PMID: 24296616 Free PMC article. - Tinkering with transcription factors uncovers plasticity of somatic cells.
Azevedo JL, Feldman RA. Azevedo JL, et al. Genes Cancer. 2010 Nov;1(11):1089-99. doi: 10.1177/1947601911401908. Genes Cancer. 2010. PMID: 21779433 Free PMC article. - Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.
Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, Donia M, Fagone P, Malaponte G, Nicoletti F, Libra M, Milella M, Tafuri A, Bonati A, Bäsecke J, Cocco L, Evangelisti C, Martelli AM, Montalto G, Cervello M, McCubrey JA. Steelman LS, et al. Aging (Albany NY). 2011 Mar;3(3):192-222. doi: 10.18632/aging.100296. Aging (Albany NY). 2011. PMID: 21422497 Free PMC article. Review. - Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Montalto G, Cervello M, Nicoletti F, Fagone P, Malaponte G, Mazzarino MC, Candido S, Libra M, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Cocco L, Evangelisti C, Chiarini F, Martelli AM. McCubrey JA, et al. Oncotarget. 2012 Sep;3(9):954-87. doi: 10.18632/oncotarget.652. Oncotarget. 2012. PMID: 23006971 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous